Moderate to severe plaque psoriasis clinical and non-clinical studies, key players, treatment evaluation, emerging therapies, treatment algorithms, pipeline analysis | Bristol-Myers Squibb, Akeso Biopharma, Jiangsu Hengrui Pharmaceutical
  Moderate-to-Severe Plaque Psoriasis Pipeline Insights, DelveInsight Moderate to severe plaque psoriasis companies include Nimbus Therapeutics, Sun Pharmaceutical Industries Limited, Suzhou Zelgen Biopharmaceuticals, GC Cell Corporation, Bioeq GmbH, Dong-A ST Co., Ltd., Can-fite Biopharma, Bio-thera solutions, AbbVie, Sinocelltech, Janssen Research and Development, Innovent Biologics,...
0 Kommentare 0 Geteilt 424 Ansichten 0 Bewertungen
Gesponsert